Title of article :
Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?
Author/Authors :
ursic-bedoya, josé st-eloi university hospital - department of hepatology, Montpellier, France , guiu, boris st-eloi university hospital - department of radiology, Montpellier, France
Abstract :
Chronic hepatitis B (CHB) affects approximately 257 million individuals worldwide, the highest prevalence being in Western Pacific WHO Region [6.2% (1)]. In highly endemic CHB regions, the 5-year cumulative incidence of hepatocellular carcinoma (HCC) ranges from 3% to 17%, depending on the presence of cirrhosis (2).
Journal title :
Hepatobiliary Surgery and Nutrition
Journal title :
Hepatobiliary Surgery and Nutrition
